Publications by authors named "Nima Badri"

Claim this Profile
A
A randomized phase I pharmacokinetic trial comparing the potential biosimilar adalimumab (CinnoRA®) with the reference product (Humira®) in healthy volunteers.
Ahmadreza Jamshidi, Araz Sabzvari, Nassim Anjidani, Ramin Shahpari, Nima Badri

Expert Opin Investig Drugs· March 2020

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis